Literature DB >> 17606905

Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3.

Charlotte L Weller1, Sarah J Collington, Adele Hartnell, Dolores M Conroy, Toshihiko Kaise, Jane E Barker, Mark S Wilson, Graham W Taylor, Peter J Jose, Timothy J Williams.   

Abstract

Mast cells are long-lived cells that are principally recognized for their effector function in helminth infections and allergic reactions. These cells are derived from pluripotential hematopoietic stem cells in the bone marrow that give rise to committed mast cell progenitors in the blood and are recruited to tissues, where they mature. Little is known about the chemotactic signals responsible for recruitment of progenitors and localization of mature mast cells. A mouse model was set up to identify possible mast cell progenitor chemoattractants produced during repeated allergen challenge in vivo. After the final challenge, the nasal mucosa was removed to produce conditioned medium, which was tested in chemotaxis assays against 2-wk murine bone marrow-derived c-kit+ mast cells (BMMC). A single peak of chemotactic activity was seen on reverse-phase HPLC with a retention time and electrospray mass spectrum consistent with prostaglandin E2 (PGE2). This lipid was found to be a highly potent chemoattractant for immature (2-wk) and also mature (10-wk) BMMC in vitro. Fluorescently labeled 2-wk c-kit+ BMMC, when injected intravenously, accumulated in response to intradermally injected PGE2. Analysis using TaqMan showed mRNA expression of the PGE2 receptors 3 (EP3) and 4 (EP4) on 2- and 10-wk BMMC. Chemotaxis induced by PGE2 was mimicked by EP3 agonists, blocked by an EP3 receptor antagonist, and partially inhibited by a MAPKK inhibitor. These results show an unexpected function for PGE2 in the chemotaxis of mast cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17606905      PMCID: PMC1913869          DOI: 10.1073/pnas.0701700104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

Review 1.  The stem cell factor, its properties and potential role in the airways.

Authors:  O Kassel; C da Silva; N Frossard
Journal:  Pulm Pharmacol Ther       Date:  2001       Impact factor: 3.410

2.  Prostaglandin E2 increases growth and motility of colorectal carcinoma cells.

Authors:  H Sheng; J Shao; M K Washington; R N DuBois
Journal:  J Biol Chem       Date:  2001-03-12       Impact factor: 5.157

3.  IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.

Authors:  Kayhan T Nouri-Aria; Charles Pilette; Mikila R Jacobson; Hiroshi Watanabe; Stephen R Durham
Journal:  J Allergy Clin Immunol       Date:  2005-07       Impact factor: 10.793

4.  Stem cell factor-induced migration of mast cells requires p38 mitogen-activated protein kinase activity.

Authors:  M Sundström; J Alfredsson; N Olsson; G Nilsson
Journal:  Exp Cell Res       Date:  2001-07-01       Impact factor: 3.905

5.  Identification of mast cell progenitors in adult mice.

Authors:  Ching-Cheng Chen; Michele A Grimbaldeston; Mindy Tsai; Irving L Weissman; Stephen J Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

6.  Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells.

Authors:  Takayuki Nakayama; Noriko Mutsuga; Lei Yao; Giovanna Tosato
Journal:  J Leukoc Biol       Date:  2005-11-07       Impact factor: 4.962

7.  Spontaneous and continuous cyclooxygenase-2-dependent prostaglandin E2 production by stromal cells in the murine small intestine lamina propria: directing the tone of the intestinal immune response.

Authors:  R D Newberry; J S McDonough; W F Stenson; R G Lorenz
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

8.  NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

Authors:  O Dormond; A Foletti; C Paroz; C Rüegg
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

9.  Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.

Authors:  X S Wang; H Y A Lau
Journal:  Allergy       Date:  2006-04       Impact factor: 13.146

10.  Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors.

Authors:  Charlotte L Weller; Sarah J Collington; Jeremy K Brown; Hugh R P Miller; Adam Al-Kashi; Peter Clark; Peter J Jose; Adele Hartnell; Timothy J Williams
Journal:  J Exp Med       Date:  2005-06-13       Impact factor: 14.307

View more
  52 in total

1.  The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo.

Authors:  Sarah J Collington; Jenny Hallgren; James E Pease; Tatiana G Jones; Barrett J Rollins; John Westwick; K Frank Austen; Timothy J Williams; Michael F Gurish; Charlotte L Weller
Journal:  J Immunol       Date:  2010-04-28       Impact factor: 5.422

2.  Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.

Authors:  Jie Tian; Isabel Lambertz; Thomas R Berton; Joyce E Rundhaug; Kaoru Kiguchi; Stephanie H Shirley; John Digiovanni; Claudio J Conti; Susan M Fischer; Robin Fuchs-Young
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

Review 3.  The role of chemokines in cutaneous immunosurveillance.

Authors:  Sioh-Yang Tan; Ben Roediger; Wolfgang Weninger
Journal:  Immunol Cell Biol       Date:  2015-03-17       Impact factor: 5.126

Review 4.  Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights.

Authors:  Daniel Elieh Ali Komi; Leif Bjermer
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

5.  Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.

Authors:  Milena Sokolowska; Li-Yuan Chen; Yueqin Liu; Asuncion Martinez-Anton; Hai-Yan Qi; Carolea Logun; Sara Alsaaty; Yong Hwan Park; Daniel L Kastner; Jae Jin Chae; James H Shelhamer
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

6.  Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266.

Authors:  J Günther; K Schulte; D Wenzel; B Malinowska; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-10       Impact factor: 3.000

7.  The function of CCR3 on mouse bone marrow-derived mast cells in vitro.

Authors:  Sarah J Collington; John Westwick; Timothy J Williams; Charlotte L Weller
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

8.  Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.

Authors:  Vinay Kondeti; Nosayba Al-Azzam; Ernest Duah; Charles K Thodeti; Joshua A Boyce; Sailaja Paruchuri
Journal:  J Allergy Clin Immunol       Date:  2015-08-05       Impact factor: 10.793

9.  Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death.

Authors:  Dong Wei; Jie Li; Miaoda Shen; Wei Jia; Nuoqi Chen; Tao Chen; Dongming Su; Haoming Tian; Shusen Zheng; Yifan Dai; Allan Zhao
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

10.  Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration.

Authors:  S Mark Duffy; Glenn Cruse; Sarah L Cockerill; Chris E Brightling; Peter Bradding
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.